½ÃÀ庸°í¼­
»óǰÄÚµå
1672719

Ä­³ªºñµð¿Ã ½ÃÀå : °ø±Þ¿ø À¯Çüº°, Á¦Ç°º°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°

Cannabidiol Market, By Source Type, By Product, By Application, By Distribution Channel, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Ä­³ªºñµð¿Ã ½ÃÀåÀº 2025³â¿¡´Â 94¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. 2032³â¿¡´Â 275¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â±îÁöÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 16.5%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 94¾ï 6,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 16.50% 2032³â ±Ý¾× ¿¹Ãø 275¾ï 7,000¸¸ ´Þ·¯
±×¸². Ä­³ªºñµð¿Ã ½ÃÀå Á¡À¯À²(%), 2025³â, Áö¿ªº°
Cannabidiol Market-IMG1

Ä­³ªºñµð¿Ã ¶Ç´Â CBD´Â ´ë¸¶¿Í ´ë¸¶¿Í °°Àº ´ë¸¶ ½Ä¹°¿¡ Æ÷ÇÔµÈ ÁÖ¿ä Ä­³ªºñ³ëÀ̵å Áß ÇϳªÀÔ´Ï´Ù. Ä­³ªºñµð¿ÃÀº THC(µ¨Å¸-9-Åׯ®¶óÇÏÀ̵å·ÎÄ­³ªºñ³î)ÀÇ ÇâÁ¤½Å ÀÛ¿ë ¾øÀÌ ¸î °¡Áö ÀáÀçÀûÀÎ ÀÇ·á È¿°ú¿Í Ä¡·á È¿°ú¸¦ ¹ßÈÖÇÕ´Ï´Ù. ºÒ¸éÁõ, ¸¸¼º ÅëÁõ, ºÒ¾È, °£Áú°ú °°Àº Áõ»ó¿¡ ´ëÇÑ CBDÀÇ Ä¡·á Ư¼º¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡´Â Ä­³ªºñµð¿Ã ÇÔÀ¯ Á¦Ç°ÀÇ Ã¤¿ëÀ» µÞ¹ÞħÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á¿ëÀ¸·Î ¿©·¯ ³ª¶ó¿¡¼­ ´ë¸¶Ãʰ¡ ÇÕ¹ýÈ­µÇ¾î Ä­³ªºñµð¿Ã Á¦Á¶¾÷ü¿Í º¥´õ¿¡°Ô »õ·Î¿î ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. CBDÀÇ À¯È¿¼º°ú ¾ÈÀü¼ºÀ» °ËÁõÇÏ´Â ´Ù¾çÇÑ ¿¬±¸°¡ ÁøÇà ÁßÀ̸ç, ¹Ì·¡ÀÇ CBD Á¦Ç°ÀÇ »ó¾÷È­ Àü¸ÁÀ» ´õ¿í È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÀÇ·á¿ë ´ë¸¶ÃÊÀÇ ÇÕ¹ýÈ­°¡ ÁøÇàµÇ°í ´ë¸¶ÃÊ ±â¹Ý Á¦Ç°ÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â °ÍÀº ¼¼°èÀÇ Ä­³ªºñµð¿Ã ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷¿¡ ÀÇÇÑ ´ë¸¶ ¿¬±¸¿Í ½ÅÁ¦Ç° Ãâ½Ã¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡, »ýȰ½À°üº´, Á¤½ÅÁúȯ, ¸¸¼ºÁúȯÀÇ À¯º´·ü »ó½ÂÀº Ä¡·á¿ë CBDÁ¦Ç° ¼ö¿ä¸¦ ³ô¿©ÁÝ´Ï´Ù. ±×·¯³ª ƯÁ¤ ±ÔÁ¦°¡ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¿´É°ú ¾ÈÀü¼º¿¡ ´ëÇÑ ÀÓ»ó°Ë»ç µ¥ÀÌÅÍÀÇ ºÎÁ·µµ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÕ´Ï´Ù. ÇÑÆí, ½Äǰ ¹× ÆÛ½º³ÎÄɾî Á¦Ç°¿¡ÀÇ Ã¤¿ëÀÌ È®´ëµÇ°í ÀÖ¾î, ½ÃÀå È®´ëÀÇ ±âȸ¸¦ Á¦°øÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

º» º¸°í¼­´Â ¼¼°èÀÇ Ä­³ªºñµð¿Ã ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.

¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ Ãâ½Ã¿Í ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ª¿¡ ÀÇÇÑ Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.

±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°èÀÇ Ä­³ªºñµð¿Ã ½ÃÀå ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.

º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷À¸·Î´Â CV Sciences, Inc., Isodiol, Medical Marijuana Inc., Aurora Cannabis, ENDOCA, Elixinol, GAIA Botanicals LLC µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¼¼°èÀÇ Ä­³ªºñµð¿Ã ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°èÀÇ Ä­³ªºñµð¿Ã ½ÃÀåÀ» ºÐ¼®ÇÏ´Â µ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map (COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±Ý Á¶´Þ ¹× ÅõÀÚ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ Ä­³ªºñµð¿Ã ½ÃÀå - Äڷγª ¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎÀÇ ´ëó
  • COVID-19¿¡ ÀÇÇÑ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ Ä­³ªºñµð¿Ã ½ÃÀå, °ø±Þ¿ø À¯Çüº°(2020-2032³â), 10¾ï ´Þ·¯

  • ¼­·Ð
  • ´ë¸¶
  • ¸¶¸®È­³ª

Á¦6Àå ¼¼°èÀÇ Ä­³ªºñµð¿Ã ½ÃÀå, Á¦Ç°º°(2020-2032³â), 10¾ï ´Þ·¯

  • ¼­·Ð
  • ¿ÀÀÏ
  • ÆÃÅ©Á¦
  • Á¾à
  • °æÇÇ ÆÐÄ¡
  • º£ÀÌÇÁ ¿ÀÀÏ
  • ºÐ¸®ÁÖ
  • Å©¸² ¹× ·Ñ¿Â
  • ĸ½¶
  • Á¤Á¦
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ Ä­³ªºñµð¿Ã ½ÃÀå, ¿ëµµº°(2020-2032³â), 10¾ï ´Þ·¯

  • ¼­·Ð
  • ÀÇ·á
  • ¸¸¼º ÅëÁõ
  • Á¤½Å Àå¾Ö
  • ¾Ï
  • ±âŸ
  • °³Àοë
  • Á¦¾à
  • À£ºù
  • ½ÄÀ½·á
  • ÆÛ½º³ÎÄÉ¾î ¹× È­Àåǰ
  • °Ç°­±â´É½Äǰ
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ Ä­³ªºñµð¿Ã ½ÃÀå, Áö¿ªº°(2020-2032³â), 10¾ï ´Þ·¯

  • ¼­·Ð
  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«

    Á¦9Àå °æÀï ±¸µµ

    • ±â¾÷ ÇÁ·ÎÆÄÀÏ
      • ENDOCA
      • Cannoid LLC
      • Medical Marijuana Inc.
      • Folium Biosciences
      • Elixinol
      • NuLeaf Naturals LLC
      • Isodiol International Inc.
      • Pharmahemp doo
      • Aurora Cannabis Inc.
      • CV Sciences
      • Medterra CBD
      • Canopy Growth Corporation
      • Aphria, Inc.
      • GW Pharmaceuticals Plc
      • Organigram Holding Inc.

    Á¦10Àå ¾Ö³Î¸®½ºÆ® Ãßõ

    • À¶¼º°ú ¼èÅð
    • ÀϰüÇü ±âȸ ¸Ê

    Á¦11Àå Âü°í¹®Çå°ú Á¶»ç¹æ¹ý

    • Âü°í¹®Çå
    • Á¶»ç¹æ¹ý
    KTH 25.03.26

    Global Cannabidiol Market is estimated to be valued at USD 9.46 Bn in 2025 and is expected to reach USD 27.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.5% from 2025 to 2032.

    Report Coverage Report Details
    Base Year: 2024 Market Size in 2025: USD 9.46 Bn
    Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
    Forecast Period 2025 to 2032 CAGR: 16.50% 2032 Value Projection: USD 27.57 Bn
    Figure. Cannabidiol Market Share (%), By Region 2025
    Cannabidiol Market - IMG1

    Cannabidiol or CBD is one of the primary cannabinoids found in cannabis plants like hemp and marijuana. It has several potential medical benefits and therapeutic effects without the psychotropic effects of THC, Delta-9-tetrahydrocannabinol. Rising awareness about the therapeutic properties of CBD for conditions like insomnia, chronic pain, anxiety, and epilepsy can boost adoption of cannabidiol-infused products. Moreover, legalization of cannabis in several countries for medical use offer new opportunities for cannabidiol manufacturers and vendors. Various studies examining the efficacy and safety of CBD are underway, which can further augment the commercialization scope of CBD products in the future.

    Market Dynamics:

    Rising legalization of medical cannabis and growing adoption of cannabis-based products can drive the global cannabidiol market growth. Increasing investments by companies in cannabis research and new product launches can drive the market growth. Furthermore, rising prevalence of lifestyle diseases, mental health disorders, and chronic conditions boosts demand for therapeutic CBD products. However, certain regulations can hamper the market growth. Lack of clinical trials data on efficacy and safety can also hamper the market growth. Meanwhile, growing adoption in food & beverages, and personal care products can offer opportunities for market expansion.

    Key Features of the Study:

    This report provides in-depth analysis of the global cannabidiol market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

    It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

    This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

    It profiles key players in the global cannabidiol market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

    Key companies covered as a part of this study include CV Sciences, Inc., Isodiol, Medical Marijuana Inc., Aurora Cannabis, ENDOCA, Elixinol and GAIA Botanicals LLC

    Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

    Global cannabidiol market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

    Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cannabidiol market

    Detailed Segmentation-

    • By Source Type
      • Hemp
      • Marijuana
    • By Product
      • Oil
      • Tinctures
      • Suppository
      • Transdermal patches
      • Vape Oil
      • Isolates
      • Creams and Roll-on
      • Capsules
      • Tablet
      • Others
    • By Application
      • Medical
      • Chronic Pain
      • Mental Disorders
      • Cancer
      • Others
      • Personal Use
      • Pharmaceuticals
      • Wellness
      • Food & Beverages
      • Personal Care & Cosmetics
      • Nutraceuticals
      • Others
    • By Distribution Channel
      • Hospital Pharmacies
      • Online Pharmacies
      • Retail Pharmacies
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
    • Company Profiles:
      • ENDOCA
      • Cannoid LLC
      • Medical Marijuana Inc.
      • Folium Biosciences
      • Elixinol
      • NuLeaf Naturals LLC
      • Isodiol International Inc.
      • Pharmahemp d.o.o.
      • Aurora Cannabis Inc.
      • CV Sciences
      • Medterra CBD
      • Canopy Growth Corporation
      • Aphria, Inc.
      • GW Pharmaceuticals Plc
      • Organigram Holding Inc.

    Table of Contents

    1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations

    2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Source Type
      • Market Snapshot, By Product
      • Market Snapshot, By Application
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)

    3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter's Analysis

    4. Global Cannabidiol Market- Impact of Coronavirus (COVID-19) Pandemic

    • Overall Impact
    • Government Initiatives
    • COVID-19 Impact on the Market

    5. Global Cannabidiol Market, By Source Type, 2020 - 2032, (USD Bn)

    • Overview
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Hemp
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Marijuana
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

    6. Global Cannabidiol Market, By Product, 2020 - 2032, (USD Bn)

    • Overview
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Oil
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Tinctures
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Suppository
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Transdermal patches
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Vape Oil
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Isolates
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Creams and Roll-on
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Capsules
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Tablet
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

    7. Global Cannabidiol Market, By Application, 2020 - 2032, (USD Bn)

    • Overview
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Medical
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Chronic Pain
    • Mental Disorders
    • Cancer
    • Others
    • Personal Use
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Pharmaceuticals
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Wellness
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Food & Beverages
    • Personal Care & Cosmetics
    • Nutraceuticals
    • Others

    8. Global Cannabidiol Market, By Region, 2020 - 2032, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, For Region, 2021-2032
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
        • North Africa
        • Central Africa
        • South Africa

    9. Competitive Landscape

    • Company Profiles
      • ENDOCA
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Cannoid LLC
      • Medical Marijuana Inc.
      • Folium Biosciences
      • Elixinol
      • NuLeaf Naturals LLC
      • Isodiol International Inc.
      • Pharmahemp d.o.o.
      • Aurora Cannabis Inc.
      • CV Sciences
      • Medterra CBD
      • Canopy Growth Corporation
      • Aphria, Inc.
      • GW Pharmaceuticals Plc
      • Organigram Holding Inc.

    10. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map

    11. References and Research Methodology

    • References
    • Research Methodology
    • About us and Sales Contact
  • ºñ±³¸®½ºÆ®
    0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
    »óǰ ºñ±³Çϱâ
    Àüü»èÁ¦